Valid

GB/Z 176-2026Biotechnology - Bioprocessing - General requirements and considerations for equipment systems used in the manufacturing of cells for therapeutic use (English PDF)

生物技术 生物过程 用于治疗用细胞制造设备系统的通用要求和考虑

Preview PDF

This is a limited preview

Buy now to download the full PDF (19 pages)

Need quotation for your management?

Get a formal quotation for GB/Z 176-2026 in 30 minutes.

Issued by

SAMR; SAC

Level / Type

National · Recommended

Issue date

April 30, 2026

Implementation date

April 30, 2026

Scope

GB/Z 176-2026 is the English-translated version of 生物技术 生物过程 用于治疗用细胞制造设备系统的通用要求和考虑.

GB/Z 176-2026 is a Chinese guiding technical document on the equipment used to manufacture cells for therapeutic use, taken over identically from ISO/TS 23565:2021. It treats hardware, software and consumables for cell isolation and sorting, expansion, washing and volume reduction, final processing and cryopreservation, seen from both the supplier and the user side across design, use and maintenance. General considerations cover fitting equipment into the manufacturing workflow, links to upstream and downstream processing, monitoring and alarm software, impurities, toxicity, sterility and pyrogenicity. Later clauses address physical integrity and strength, cell recovery, cell damage, cleanroom impact, biocompatibility, extractables and leachables, particulate matter, single-use component stability, documentation and change notification. Bedside cell processing equipment, analytical instruments, biosafety cabinets and standard culture equipment such as CO2 incubators are excluded. It was issued on 30 April 2026.

Found what you need?

Document preview — GB/Z 176-2026

National Standard of the People's Republic of China

ICS
07.080
Classification
A 40

Issued by: State Administration for Market Regulation; Standardization Administration of the PRC

Contents

  • Preface
  • 1.Scope
  • 2 Normative References
  • 3.Terms and Definitions
  • 4.General Considerations
  • 4.1 General Provisions
  • 4.2 Integrating equipment and testing into the manufacturing workflow of therapeutic cells
  • 4.3 Unit Operation Equipment System
  • 4.4 Connect to upstream or downstream processing equipment, or both.
  • 4.5 Monitoring and Early Warning Software
  • 4.6 Effects of impurities and toxicity on cells used in final therapeutic applications
  • 4.7 Sterility and pyrogenicity
  • 5.Overall performance characteristics and evaluation of the equipment
  • 5.1 General Provisions
  • 5.2 Performance Characteristics Description
  • 5.3 Performance parameters and their correlation with cell quality attributes
  • 6.Equipment System Composition
  • 6.1 Hardware
  • 6.1.1 General Provisions
  • 6.1.2 Physical Integrity
  • 6.1.3 Physical Strength
  • 6.1.4 Packaging
  • 6.1.5 Cell Recovery
  • 6.1.6 Performance Verification
  • 6.1.7 Physical assessment of the interaction between the device and the cell sample
  • 6.1.8 Cell damage
  • 6.1.9 Impact on the cleanroom environment
  • 6.1.10 Monitoring
  • 6.2 Software for Manufacturing Therapeutic Cells
  • 6.3 Consumables
  • 6.3.1 General Provisions
  • 6.3.2 Biocompatibility
  • 6.3.3 Toxicity of Chemical Sterilizers
  • 6.3.4 Toxicity of Extracts and Leachates
  • 6.3.5 Particulate matter
  • 6.3.6 Stability of single-use components
  • 7.Documentation and Notification of Changes
  • 7.1 Document Record
  • 7.1.1 General Provisions
  • 7.1.2 Documentation records for commercially available equipment or instruments
  • 7.1.3 Supplier document package for customized design of equipment or instruments
  • 8.Equipment Use and Maintenance
  • 8.1 Equipment usage
  • 8.2 Equipment Maintenance
  • Reference

Foreword

This document is a standard or guiding technical document.

This document complies with the provisions of GB/T 1.1-2020 "Standardization Work Guidelines Part 1: Structure and Drafting Rules of Standardization Documents". Drafting.

This document is equivalent to ISO /T S23565.2021 "Biotechnology, Bioprocesses - Equipment and Systems for Therapeutic Cell Manufacturing".

The document type, "Requirements and Considerations," has been changed from an ISO technical specification to a national standardization guidance technical document in my country.

1 Scope

This document specifies the basic requirements and general considerations for therapeutic cell manufacturing equipment (including hardware, software, and consumables). This includes equipment used for... Equipment for therapeutic cells, from cell isolation/sorting, expansion, washing and volume reduction, to final cell processing and application in therapeutic applications. Cryopreservation of cells.

This document addresses the needs of suppliers and users from the perspectives of the target party (i.e., supplier or user) and the relevant task phases (i.e., design, use, or maintenance).

It provides guidance on the design, use, and maintenance of equipment and equipment systems.

This document applies to any unit operating system used for the manufacture of therapeutic cells that meets user requirements, whether used alone or in combination.

This document is applicable to equipment used for monitoring device status.

This document does not apply to.

---Cell processing equipment for bedside therapy;

--- Equipment used for analytical purposes;

---Biosafety cabinets, standard cell culture equipment (such as CO2 incubators), and control systems for multiple devices or multiple unit operations. The software.

2 Normative references

This document has no normative references.

3 Terms and Definitions

The following terms and definitions apply to this document.

The URLs for the terminology databases maintained by ISO and IEC for standardization are as follows.

3.1 Batch

The quantity of material is considered as a single unit and has a unique reference identifier.

Note: Batch is primarily a processing term.

[Source: ISO 15270:2008, 3.3]

3.2 Products that use cells as active substances

Examples. Cell therapy pharmaceutical products (allogeneic, autologous, somatic cell, genetically modified), tissue engineering products.

Note: In this document, "cell" refers to human cells and autologous and allogeneic tissues.

[Source: ISO 21973:2020, 3.1, with modifications]

......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 19 pages — is available in the English PDF.

Similar standards

How to Download GB/Z 176-2026

  1. 1

    Add to cart

    Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.

  2. 2

    Checkout

    Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).

  3. 3

    Instant delivery (0–9 sec)

    Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.

  4. 4

    Invoice included

    A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.

Related Standards

English PDF
19 pages
Instant delivery (0–9 sec)
Invoice included
View Cart

Secure payment via Stripe

Payments accepted

VisaMastercardAmerican ExpressApple PayGoogle PayStripe

GB/Z 176-2026

$365.00